Corpus
PascalFrancis
Racine
Corpus
Checkpoint
PascalFrancis
Racine
PascalFrancis
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection : Patient Perceptions and Precautionary Behaviors

Identifieur interne : 000358 ( PascalFrancis/Corpus ); précédent : 000357; suivant : 000359

Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection : Patient Perceptions and Precautionary Behaviors

Auteurs : Sarah A. Mclaughlin ; Mary J. Wright ; Katherine T. Morris ; Michelle R. Sampson ; Julia P. Brockway ; Karen E. Hurley ; Elyn R. Riedel ; Kimberly J. Van Zee

Source :

RBID : Pascal:09-0008449

Descripteurs français

English descriptors

Abstract

Purpose Sentinel lymph node (SLN) biopsy was adopted for the staging of the axilla with the assumption that it would reduce the risk of lymphedema in women with breast cancer. This study was undertaken to examine patient perceptions of lymphedema and use of precautionary behaviors several years after axillary surgery. Patients and Methods Nine hundred thirty-six women who underwent SLN biopsy (SLNB) alone or SLNB followed by axillary lymph node dissection (SLNB/ALND) between June 1, 1999, and May 30, 2003, were evaluated at a median of 5 years after surgery. Patient-perceived lymphedema and avoidant behaviors were assessed through interview and administered a validated instrument, and compared with arm measurements. Results Current arm swelling was reported in 3% of patients who received SLNB alone versus 27% of patients who received SLNB/ALND (P <.0001), as compared with 5% and 16%, respectively, with measured lymphedema. Only 41 % of patients reporting arm swelling had measured lymphedema, and 5% of patients reporting no arm swelling had measured lymphedema. Risk factors associated with reported arm swelling were greater body weight (P <.0001), higher body mass index (P <.0001), infection (P <.0001), and injury (P =.007) in the ipsilateral arm since surgery. Patients followed more precautions if they had measured or perceived lymphedema. Conclusion Body weight, infection, and injury are significant risk factors for perceiving lymphedema. There is significant discordance between the presence of measured and patient-perceived lymphedema. When compared to SLNB/ALND, SLNB-alone results in a significantly lower rate of patient-perceived arm swelling 5 years postoperatively, and is perceived by fewer women than are measured to have it.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0732-183X
A03   1    @0 J. clin. oncol.
A05       @2 26
A06       @2 32
A08 01  1  ENG  @1 Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection : Patient Perceptions and Precautionary Behaviors
A11 01  1    @1 MCLAUGHLIN (Sarah A.)
A11 02  1    @1 WRIGHT (Mary J.)
A11 03  1    @1 MORRIS (Katherine T.)
A11 04  1    @1 SAMPSON (Michelle R.)
A11 05  1    @1 BROCKWAY (Julia P.)
A11 06  1    @1 HURLEY (Karen E.)
A11 07  1    @1 RIEDEL (Elyn R.)
A11 08  1    @1 VAN ZEE (Kimberly J.)
A14 01      @1 Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center @2 New York, NY @3 USA
A14 02      @1 Behavioral Science Service, Department of Psychiatry and Behavorial Science, Memorial Sloan-Kettering Cancer Center @2 New York, NY @3 USA
A14 03      @1 Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center @2 New York, NY @3 USA
A20       @1 5220-5226
A21       @1 2008
A23 01      @0 ENG
A43 01      @1 INIST @2 20094 @5 354000184373440140
A44       @0 0000 @1 © 2009 INIST-CNRS. All rights reserved.
A45       @0 12 ref.
A47 01  1    @0 09-0008449
A60       @1 P
A61       @0 A
A64 01  1    @0 Journal of clinical oncology
A66 01      @0 USA
C01 01    ENG  @0 Purpose Sentinel lymph node (SLN) biopsy was adopted for the staging of the axilla with the assumption that it would reduce the risk of lymphedema in women with breast cancer. This study was undertaken to examine patient perceptions of lymphedema and use of precautionary behaviors several years after axillary surgery. Patients and Methods Nine hundred thirty-six women who underwent SLN biopsy (SLNB) alone or SLNB followed by axillary lymph node dissection (SLNB/ALND) between June 1, 1999, and May 30, 2003, were evaluated at a median of 5 years after surgery. Patient-perceived lymphedema and avoidant behaviors were assessed through interview and administered a validated instrument, and compared with arm measurements. Results Current arm swelling was reported in 3% of patients who received SLNB alone versus 27% of patients who received SLNB/ALND (P <.0001), as compared with 5% and 16%, respectively, with measured lymphedema. Only 41 % of patients reporting arm swelling had measured lymphedema, and 5% of patients reporting no arm swelling had measured lymphedema. Risk factors associated with reported arm swelling were greater body weight (P <.0001), higher body mass index (P <.0001), infection (P <.0001), and injury (P =.007) in the ipsilateral arm since surgery. Patients followed more precautions if they had measured or perceived lymphedema. Conclusion Body weight, infection, and injury are significant risk factors for perceiving lymphedema. There is significant discordance between the presence of measured and patient-perceived lymphedema. When compared to SLNB/ALND, SLNB-alone results in a significantly lower rate of patient-perceived arm swelling 5 years postoperatively, and is perceived by fewer women than are measured to have it.
C02 01  X    @0 002B04
C02 02  X    @0 002B12B04
C03 01  X  FRE  @0 Lymphoedème @5 01
C03 01  X  ENG  @0 Lymphedema @5 01
C03 01  X  SPA  @0 Linfedema @5 01
C03 02  X  FRE  @0 Prévalence @5 02
C03 02  X  ENG  @0 Prevalence @5 02
C03 02  X  SPA  @0 Prevalencia @5 02
C03 03  X  FRE  @0 Epidémiologie @5 03
C03 03  X  ENG  @0 Epidemiology @5 03
C03 03  X  SPA  @0 Epidemiología @5 03
C03 04  X  FRE  @0 Cancer du sein @2 NM @5 04
C03 04  X  ENG  @0 Breast cancer @2 NM @5 04
C03 04  X  SPA  @0 Cáncer del pecho @2 NM @5 04
C03 05  X  FRE  @0 Homme @5 05
C03 05  X  ENG  @0 Human @5 05
C03 05  X  SPA  @0 Hombre @5 05
C03 06  X  FRE  @0 Femelle @5 06
C03 06  X  ENG  @0 Female @5 06
C03 06  X  SPA  @0 Hembra @5 06
C03 07  X  FRE  @0 Biopsie @5 07
C03 07  X  ENG  @0 Biopsy @5 07
C03 07  X  SPA  @0 Biopsia @5 07
C03 08  X  FRE  @0 Adulte @5 08
C03 08  X  ENG  @0 Adult @5 08
C03 08  X  SPA  @0 Adulto @5 08
C03 09  X  FRE  @0 Femme @5 09
C03 09  X  ENG  @0 Woman @5 09
C03 09  X  SPA  @0 Mujer @5 09
C03 10  X  FRE  @0 Anatomopathologie @5 10
C03 10  X  ENG  @0 Anatomic pathology @5 10
C03 10  X  SPA  @0 Anatomía patológica @5 10
C03 11  X  FRE  @0 Ganglion sentinelle @5 11
C03 11  X  ENG  @0 Sentinel lymph node @5 11
C03 11  X  SPA  @0 Ganglio centinela @5 11
C03 12  X  FRE  @0 Lymphadénectomie @5 12
C03 12  X  ENG  @0 Lymphadenectomy @5 12
C03 12  X  SPA  @0 Linfadenectomía @5 12
C03 13  X  FRE  @0 Axillaire @5 17
C03 13  X  ENG  @0 Axillary @5 17
C03 13  X  SPA  @0 Axilar @5 17
C03 14  X  FRE  @0 Perception @5 18
C03 14  X  ENG  @0 Perception @5 18
C03 14  X  SPA  @0 Percepción @5 18
C03 15  X  FRE  @0 Comportement @5 19
C03 15  X  ENG  @0 Behavior @5 19
C03 15  X  SPA  @0 Conducta @5 19
C03 16  X  FRE  @0 Cancérologie @5 20
C03 16  X  ENG  @0 Cancerology @5 20
C03 16  X  SPA  @0 Cancerología @5 20
C03 17  X  FRE  @0 Traitement @5 25
C03 17  X  ENG  @0 Treatment @5 25
C03 17  X  SPA  @0 Tratamiento @5 25
C07 01  X  FRE  @0 Pathologie de l'appareil circulatoire @5 37
C07 01  X  ENG  @0 Cardiovascular disease @5 37
C07 01  X  SPA  @0 Aparato circulatorio patología @5 37
C07 02  X  FRE  @0 Pathologie des vaisseaux lymphatiques @5 38
C07 02  X  ENG  @0 Lymphatic vessel disease @5 38
C07 02  X  SPA  @0 Linfático patología @5 38
C07 03  X  FRE  @0 Tumeur maligne @2 NM @5 39
C07 03  X  ENG  @0 Malignant tumor @2 NM @5 39
C07 03  X  SPA  @0 Tumor maligno @2 NM @5 39
C07 04  X  FRE  @0 Cancer @2 NM
C07 04  X  ENG  @0 Cancer @2 NM
C07 04  X  SPA  @0 Cáncer @2 NM
C07 05  X  FRE  @0 Pathologie de la glande mammaire @2 NM @5 40
C07 05  X  ENG  @0 Mammary gland diseases @2 NM @5 40
C07 05  X  SPA  @0 Glándula mamaria patología @2 NM @5 40
C07 06  X  FRE  @0 Pathologie du sein @2 NM @5 41
C07 06  X  ENG  @0 Breast disease @2 NM @5 41
C07 06  X  SPA  @0 Seno patología @2 NM @5 41
C07 07  X  FRE  @0 Chirurgie @5 42
C07 07  X  ENG  @0 Surgery @5 42
C07 07  X  SPA  @0 Cirugía @5 42
N21       @1 004
N44 01      @1 OTO
N82       @1 OTO

Format Inist (serveur)

NO : PASCAL 09-0008449 INIST
ET : Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection : Patient Perceptions and Precautionary Behaviors
AU : MCLAUGHLIN (Sarah A.); WRIGHT (Mary J.); MORRIS (Katherine T.); SAMPSON (Michelle R.); BROCKWAY (Julia P.); HURLEY (Karen E.); RIEDEL (Elyn R.); VAN ZEE (Kimberly J.)
AF : Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center/New York, NY/Etats-Unis; Behavioral Science Service, Department of Psychiatry and Behavorial Science, Memorial Sloan-Kettering Cancer Center/New York, NY/Etats-Unis; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center/New York, NY/Etats-Unis
DT : Publication en série; Niveau analytique
SO : Journal of clinical oncology; ISSN 0732-183X; Etats-Unis; Da. 2008; Vol. 26; No. 32; Pp. 5220-5226; Bibl. 12 ref.
LA : Anglais
EA : Purpose Sentinel lymph node (SLN) biopsy was adopted for the staging of the axilla with the assumption that it would reduce the risk of lymphedema in women with breast cancer. This study was undertaken to examine patient perceptions of lymphedema and use of precautionary behaviors several years after axillary surgery. Patients and Methods Nine hundred thirty-six women who underwent SLN biopsy (SLNB) alone or SLNB followed by axillary lymph node dissection (SLNB/ALND) between June 1, 1999, and May 30, 2003, were evaluated at a median of 5 years after surgery. Patient-perceived lymphedema and avoidant behaviors were assessed through interview and administered a validated instrument, and compared with arm measurements. Results Current arm swelling was reported in 3% of patients who received SLNB alone versus 27% of patients who received SLNB/ALND (P <.0001), as compared with 5% and 16%, respectively, with measured lymphedema. Only 41 % of patients reporting arm swelling had measured lymphedema, and 5% of patients reporting no arm swelling had measured lymphedema. Risk factors associated with reported arm swelling were greater body weight (P <.0001), higher body mass index (P <.0001), infection (P <.0001), and injury (P =.007) in the ipsilateral arm since surgery. Patients followed more precautions if they had measured or perceived lymphedema. Conclusion Body weight, infection, and injury are significant risk factors for perceiving lymphedema. There is significant discordance between the presence of measured and patient-perceived lymphedema. When compared to SLNB/ALND, SLNB-alone results in a significantly lower rate of patient-perceived arm swelling 5 years postoperatively, and is perceived by fewer women than are measured to have it.
CC : 002B04; 002B12B04
FD : Lymphoedème; Prévalence; Epidémiologie; Cancer du sein; Homme; Femelle; Biopsie; Adulte; Femme; Anatomopathologie; Ganglion sentinelle; Lymphadénectomie; Axillaire; Perception; Comportement; Cancérologie; Traitement
FG : Pathologie de l'appareil circulatoire; Pathologie des vaisseaux lymphatiques; Tumeur maligne; Cancer; Pathologie de la glande mammaire; Pathologie du sein; Chirurgie
ED : Lymphedema; Prevalence; Epidemiology; Breast cancer; Human; Female; Biopsy; Adult; Woman; Anatomic pathology; Sentinel lymph node; Lymphadenectomy; Axillary; Perception; Behavior; Cancerology; Treatment
EG : Cardiovascular disease; Lymphatic vessel disease; Malignant tumor; Cancer; Mammary gland diseases; Breast disease; Surgery
SD : Linfedema; Prevalencia; Epidemiología; Cáncer del pecho; Hombre; Hembra; Biopsia; Adulto; Mujer; Anatomía patológica; Ganglio centinela; Linfadenectomía; Axilar; Percepción; Conducta; Cancerología; Tratamiento
LO : INIST-20094.354000184373440140
ID : 09-0008449

Links to Exploration step

Pascal:09-0008449

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection : Patient Perceptions and Precautionary Behaviors</title>
<author>
<name sortKey="Mclaughlin, Sarah A" sort="Mclaughlin, Sarah A" uniqKey="Mclaughlin S" first="Sarah A." last="Mclaughlin">Sarah A. Mclaughlin</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="02">
<s1>Behavioral Science Service, Department of Psychiatry and Behavorial Science, Memorial Sloan-Kettering Cancer Center</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="03">
<s1>Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Wright, Mary J" sort="Wright, Mary J" uniqKey="Wright M" first="Mary J." last="Wright">Mary J. Wright</name>
</author>
<author>
<name sortKey="Morris, Katherine T" sort="Morris, Katherine T" uniqKey="Morris K" first="Katherine T." last="Morris">Katherine T. Morris</name>
</author>
<author>
<name sortKey="Sampson, Michelle R" sort="Sampson, Michelle R" uniqKey="Sampson M" first="Michelle R." last="Sampson">Michelle R. Sampson</name>
</author>
<author>
<name sortKey="Brockway, Julia P" sort="Brockway, Julia P" uniqKey="Brockway J" first="Julia P." last="Brockway">Julia P. Brockway</name>
</author>
<author>
<name sortKey="Hurley, Karen E" sort="Hurley, Karen E" uniqKey="Hurley K" first="Karen E." last="Hurley">Karen E. Hurley</name>
</author>
<author>
<name sortKey="Riedel, Elyn R" sort="Riedel, Elyn R" uniqKey="Riedel E" first="Elyn R." last="Riedel">Elyn R. Riedel</name>
</author>
<author>
<name sortKey="Van Zee, Kimberly J" sort="Van Zee, Kimberly J" uniqKey="Van Zee K" first="Kimberly J." last="Van Zee">Kimberly J. Van Zee</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">09-0008449</idno>
<date when="2008">2008</date>
<idno type="stanalyst">PASCAL 09-0008449 INIST</idno>
<idno type="RBID">Pascal:09-0008449</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000358</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection : Patient Perceptions and Precautionary Behaviors</title>
<author>
<name sortKey="Mclaughlin, Sarah A" sort="Mclaughlin, Sarah A" uniqKey="Mclaughlin S" first="Sarah A." last="Mclaughlin">Sarah A. Mclaughlin</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="02">
<s1>Behavioral Science Service, Department of Psychiatry and Behavorial Science, Memorial Sloan-Kettering Cancer Center</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="03">
<s1>Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Wright, Mary J" sort="Wright, Mary J" uniqKey="Wright M" first="Mary J." last="Wright">Mary J. Wright</name>
</author>
<author>
<name sortKey="Morris, Katherine T" sort="Morris, Katherine T" uniqKey="Morris K" first="Katherine T." last="Morris">Katherine T. Morris</name>
</author>
<author>
<name sortKey="Sampson, Michelle R" sort="Sampson, Michelle R" uniqKey="Sampson M" first="Michelle R." last="Sampson">Michelle R. Sampson</name>
</author>
<author>
<name sortKey="Brockway, Julia P" sort="Brockway, Julia P" uniqKey="Brockway J" first="Julia P." last="Brockway">Julia P. Brockway</name>
</author>
<author>
<name sortKey="Hurley, Karen E" sort="Hurley, Karen E" uniqKey="Hurley K" first="Karen E." last="Hurley">Karen E. Hurley</name>
</author>
<author>
<name sortKey="Riedel, Elyn R" sort="Riedel, Elyn R" uniqKey="Riedel E" first="Elyn R." last="Riedel">Elyn R. Riedel</name>
</author>
<author>
<name sortKey="Van Zee, Kimberly J" sort="Van Zee, Kimberly J" uniqKey="Van Zee K" first="Kimberly J." last="Van Zee">Kimberly J. Van Zee</name>
</author>
</analytic>
<series>
<title level="j" type="main">Journal of clinical oncology</title>
<title level="j" type="abbreviated">J. clin. oncol.</title>
<idno type="ISSN">0732-183X</idno>
<imprint>
<date when="2008">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Journal of clinical oncology</title>
<title level="j" type="abbreviated">J. clin. oncol.</title>
<idno type="ISSN">0732-183X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Anatomic pathology</term>
<term>Axillary</term>
<term>Behavior</term>
<term>Biopsy</term>
<term>Breast cancer</term>
<term>Cancerology</term>
<term>Epidemiology</term>
<term>Female</term>
<term>Human</term>
<term>Lymphadenectomy</term>
<term>Lymphedema</term>
<term>Perception</term>
<term>Prevalence</term>
<term>Sentinel lymph node</term>
<term>Treatment</term>
<term>Woman</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Lymphoedème</term>
<term>Prévalence</term>
<term>Epidémiologie</term>
<term>Cancer du sein</term>
<term>Homme</term>
<term>Femelle</term>
<term>Biopsie</term>
<term>Adulte</term>
<term>Femme</term>
<term>Anatomopathologie</term>
<term>Ganglion sentinelle</term>
<term>Lymphadénectomie</term>
<term>Axillaire</term>
<term>Perception</term>
<term>Comportement</term>
<term>Cancérologie</term>
<term>Traitement</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Purpose Sentinel lymph node (SLN) biopsy was adopted for the staging of the axilla with the assumption that it would reduce the risk of lymphedema in women with breast cancer. This study was undertaken to examine patient perceptions of lymphedema and use of precautionary behaviors several years after axillary surgery. Patients and Methods Nine hundred thirty-six women who underwent SLN biopsy (SLNB) alone or SLNB followed by axillary lymph node dissection (SLNB/ALND) between June 1, 1999, and May 30, 2003, were evaluated at a median of 5 years after surgery. Patient-perceived lymphedema and avoidant behaviors were assessed through interview and administered a validated instrument, and compared with arm measurements. Results Current arm swelling was reported in 3% of patients who received SLNB alone versus 27% of patients who received SLNB/ALND (P <.0001), as compared with 5% and 16%, respectively, with measured lymphedema. Only 41 % of patients reporting arm swelling had measured lymphedema, and 5% of patients reporting no arm swelling had measured lymphedema. Risk factors associated with reported arm swelling were greater body weight (P <.0001), higher body mass index (P <.0001), infection (P <.0001), and injury (P =.007) in the ipsilateral arm since surgery. Patients followed more precautions if they had measured or perceived lymphedema. Conclusion Body weight, infection, and injury are significant risk factors for perceiving lymphedema. There is significant discordance between the presence of measured and patient-perceived lymphedema. When compared to SLNB/ALND, SLNB-alone results in a significantly lower rate of patient-perceived arm swelling 5 years postoperatively, and is perceived by fewer women than are measured to have it.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0732-183X</s0>
</fA01>
<fA03 i2="1">
<s0>J. clin. oncol.</s0>
</fA03>
<fA05>
<s2>26</s2>
</fA05>
<fA06>
<s2>32</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection : Patient Perceptions and Precautionary Behaviors</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>MCLAUGHLIN (Sarah A.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>WRIGHT (Mary J.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>MORRIS (Katherine T.)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>SAMPSON (Michelle R.)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>BROCKWAY (Julia P.)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>HURLEY (Karen E.)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>RIEDEL (Elyn R.)</s1>
</fA11>
<fA11 i1="08" i2="1">
<s1>VAN ZEE (Kimberly J.)</s1>
</fA11>
<fA14 i1="01">
<s1>Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
</fA14>
<fA14 i1="02">
<s1>Behavioral Science Service, Department of Psychiatry and Behavorial Science, Memorial Sloan-Kettering Cancer Center</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
</fA14>
<fA14 i1="03">
<s1>Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
</fA14>
<fA20>
<s1>5220-5226</s1>
</fA20>
<fA21>
<s1>2008</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>20094</s2>
<s5>354000184373440140</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2009 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>12 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>09-0008449</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Journal of clinical oncology</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Purpose Sentinel lymph node (SLN) biopsy was adopted for the staging of the axilla with the assumption that it would reduce the risk of lymphedema in women with breast cancer. This study was undertaken to examine patient perceptions of lymphedema and use of precautionary behaviors several years after axillary surgery. Patients and Methods Nine hundred thirty-six women who underwent SLN biopsy (SLNB) alone or SLNB followed by axillary lymph node dissection (SLNB/ALND) between June 1, 1999, and May 30, 2003, were evaluated at a median of 5 years after surgery. Patient-perceived lymphedema and avoidant behaviors were assessed through interview and administered a validated instrument, and compared with arm measurements. Results Current arm swelling was reported in 3% of patients who received SLNB alone versus 27% of patients who received SLNB/ALND (P <.0001), as compared with 5% and 16%, respectively, with measured lymphedema. Only 41 % of patients reporting arm swelling had measured lymphedema, and 5% of patients reporting no arm swelling had measured lymphedema. Risk factors associated with reported arm swelling were greater body weight (P <.0001), higher body mass index (P <.0001), infection (P <.0001), and injury (P =.007) in the ipsilateral arm since surgery. Patients followed more precautions if they had measured or perceived lymphedema. Conclusion Body weight, infection, and injury are significant risk factors for perceiving lymphedema. There is significant discordance between the presence of measured and patient-perceived lymphedema. When compared to SLNB/ALND, SLNB-alone results in a significantly lower rate of patient-perceived arm swelling 5 years postoperatively, and is perceived by fewer women than are measured to have it.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B04</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B12B04</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Lymphoedème</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Lymphedema</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Linfedema</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Prévalence</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Prevalence</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Prevalencia</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Epidémiologie</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Epidemiology</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Epidemiología</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Cancer du sein</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Breast cancer</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Cáncer del pecho</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Homme</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Human</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Hombre</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Femelle</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Female</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Hembra</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Biopsie</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Biopsy</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Biopsia</s0>
<s5>07</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Adulte</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Adult</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Adulto</s0>
<s5>08</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Femme</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Woman</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Mujer</s0>
<s5>09</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE">
<s0>Anatomopathologie</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG">
<s0>Anatomic pathology</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA">
<s0>Anatomía patológica</s0>
<s5>10</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE">
<s0>Ganglion sentinelle</s0>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG">
<s0>Sentinel lymph node</s0>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA">
<s0>Ganglio centinela</s0>
<s5>11</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE">
<s0>Lymphadénectomie</s0>
<s5>12</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG">
<s0>Lymphadenectomy</s0>
<s5>12</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA">
<s0>Linfadenectomía</s0>
<s5>12</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE">
<s0>Axillaire</s0>
<s5>17</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG">
<s0>Axillary</s0>
<s5>17</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA">
<s0>Axilar</s0>
<s5>17</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE">
<s0>Perception</s0>
<s5>18</s5>
</fC03>
<fC03 i1="14" i2="X" l="ENG">
<s0>Perception</s0>
<s5>18</s5>
</fC03>
<fC03 i1="14" i2="X" l="SPA">
<s0>Percepción</s0>
<s5>18</s5>
</fC03>
<fC03 i1="15" i2="X" l="FRE">
<s0>Comportement</s0>
<s5>19</s5>
</fC03>
<fC03 i1="15" i2="X" l="ENG">
<s0>Behavior</s0>
<s5>19</s5>
</fC03>
<fC03 i1="15" i2="X" l="SPA">
<s0>Conducta</s0>
<s5>19</s5>
</fC03>
<fC03 i1="16" i2="X" l="FRE">
<s0>Cancérologie</s0>
<s5>20</s5>
</fC03>
<fC03 i1="16" i2="X" l="ENG">
<s0>Cancerology</s0>
<s5>20</s5>
</fC03>
<fC03 i1="16" i2="X" l="SPA">
<s0>Cancerología</s0>
<s5>20</s5>
</fC03>
<fC03 i1="17" i2="X" l="FRE">
<s0>Traitement</s0>
<s5>25</s5>
</fC03>
<fC03 i1="17" i2="X" l="ENG">
<s0>Treatment</s0>
<s5>25</s5>
</fC03>
<fC03 i1="17" i2="X" l="SPA">
<s0>Tratamiento</s0>
<s5>25</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Pathologie de l'appareil circulatoire</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Cardiovascular disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Aparato circulatorio patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Pathologie des vaisseaux lymphatiques</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Lymphatic vessel disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Linfático patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Tumeur maligne</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Malignant tumor</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Tumor maligno</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Cancer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Cancer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Cáncer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Pathologie de la glande mammaire</s0>
<s2>NM</s2>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Mammary gland diseases</s0>
<s2>NM</s2>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Glándula mamaria patología</s0>
<s2>NM</s2>
<s5>40</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Pathologie du sein</s0>
<s2>NM</s2>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Breast disease</s0>
<s2>NM</s2>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Seno patología</s0>
<s2>NM</s2>
<s5>41</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE">
<s0>Chirurgie</s0>
<s5>42</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG">
<s0>Surgery</s0>
<s5>42</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA">
<s0>Cirugía</s0>
<s5>42</s5>
</fC07>
<fN21>
<s1>004</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
<server>
<NO>PASCAL 09-0008449 INIST</NO>
<ET>Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection : Patient Perceptions and Precautionary Behaviors</ET>
<AU>MCLAUGHLIN (Sarah A.); WRIGHT (Mary J.); MORRIS (Katherine T.); SAMPSON (Michelle R.); BROCKWAY (Julia P.); HURLEY (Karen E.); RIEDEL (Elyn R.); VAN ZEE (Kimberly J.)</AU>
<AF>Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center/New York, NY/Etats-Unis; Behavioral Science Service, Department of Psychiatry and Behavorial Science, Memorial Sloan-Kettering Cancer Center/New York, NY/Etats-Unis; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center/New York, NY/Etats-Unis</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Journal of clinical oncology; ISSN 0732-183X; Etats-Unis; Da. 2008; Vol. 26; No. 32; Pp. 5220-5226; Bibl. 12 ref.</SO>
<LA>Anglais</LA>
<EA>Purpose Sentinel lymph node (SLN) biopsy was adopted for the staging of the axilla with the assumption that it would reduce the risk of lymphedema in women with breast cancer. This study was undertaken to examine patient perceptions of lymphedema and use of precautionary behaviors several years after axillary surgery. Patients and Methods Nine hundred thirty-six women who underwent SLN biopsy (SLNB) alone or SLNB followed by axillary lymph node dissection (SLNB/ALND) between June 1, 1999, and May 30, 2003, were evaluated at a median of 5 years after surgery. Patient-perceived lymphedema and avoidant behaviors were assessed through interview and administered a validated instrument, and compared with arm measurements. Results Current arm swelling was reported in 3% of patients who received SLNB alone versus 27% of patients who received SLNB/ALND (P <.0001), as compared with 5% and 16%, respectively, with measured lymphedema. Only 41 % of patients reporting arm swelling had measured lymphedema, and 5% of patients reporting no arm swelling had measured lymphedema. Risk factors associated with reported arm swelling were greater body weight (P <.0001), higher body mass index (P <.0001), infection (P <.0001), and injury (P =.007) in the ipsilateral arm since surgery. Patients followed more precautions if they had measured or perceived lymphedema. Conclusion Body weight, infection, and injury are significant risk factors for perceiving lymphedema. There is significant discordance between the presence of measured and patient-perceived lymphedema. When compared to SLNB/ALND, SLNB-alone results in a significantly lower rate of patient-perceived arm swelling 5 years postoperatively, and is perceived by fewer women than are measured to have it.</EA>
<CC>002B04; 002B12B04</CC>
<FD>Lymphoedème; Prévalence; Epidémiologie; Cancer du sein; Homme; Femelle; Biopsie; Adulte; Femme; Anatomopathologie; Ganglion sentinelle; Lymphadénectomie; Axillaire; Perception; Comportement; Cancérologie; Traitement</FD>
<FG>Pathologie de l'appareil circulatoire; Pathologie des vaisseaux lymphatiques; Tumeur maligne; Cancer; Pathologie de la glande mammaire; Pathologie du sein; Chirurgie</FG>
<ED>Lymphedema; Prevalence; Epidemiology; Breast cancer; Human; Female; Biopsy; Adult; Woman; Anatomic pathology; Sentinel lymph node; Lymphadenectomy; Axillary; Perception; Behavior; Cancerology; Treatment</ED>
<EG>Cardiovascular disease; Lymphatic vessel disease; Malignant tumor; Cancer; Mammary gland diseases; Breast disease; Surgery</EG>
<SD>Linfedema; Prevalencia; Epidemiología; Cáncer del pecho; Hombre; Hembra; Biopsia; Adulto; Mujer; Anatomía patológica; Ganglio centinela; Linfadenectomía; Axilar; Percepción; Conducta; Cancerología; Tratamiento</SD>
<LO>INIST-20094.354000184373440140</LO>
<ID>09-0008449</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000358 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000358 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:09-0008449
   |texte=   Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection : Patient Perceptions and Precautionary Behaviors
}}
Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024